1887

n Cardiovascular Journal of South Africa - INVEST endorses VerapamilSR in hypertensives with CAD and highlights diabetes prevention : drug trends in cardiology

Volume 14, Issue 4
  • ISSN : 1680-0745
USD

 

Abstract

Extracted from text ... INVEST endorses VerapamilSR in hypertensives with CAD and highlights diabetes prevention The results of INVEST (International VerapamilSR/Trandolapril Study) were presented recently at the American College of Cardiology Meeting by chief investigator, Carl J. Pepine of the Cardiovascular Medicine Division, University of Florida. A follow-up satellite meeting was held in South Africa in June in order to brief local specialists on the importance of this exciting new study. The INVEST study of 22 576 hypertensive patients with CAD compared the risk for adverse outcomes [all-cause mortality, non-fatal myocardial infarction (MI) or non-fatal stroke] using either a non-dihydropyridine calcium antagonist-based (VerapamilSR) or ..

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/cardio/14/4/EJC23849
2003-07-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error